Swift approval for Bharat Biotech's indigenous Covid-19 vaccine and Serum Institute of India's version of the Oxford-AstraZeneca vaccine has raised more doubts than enthusiasm. We talk to Dr. Amar Jesani, Editor of the Indian Journal of Medical Ethics, and ET’s Divya Rajagopal to understand the concerns
See omnystudio.com/listener for privacy information.
